Ying Huang

Dr. Ying Huang joined Invivoscribe in 2010 and currently serves as the Sr. Director of Product Development. In this role, she is responsible for leading Invivoscribe’s product development activities to address unmet clinical needs in the fields of molecular diagnostic and precision medicine.

Dr. Huang has over 25 years of research and industry experience with a broad knowledge in technology and assay development. She is passionate about developing novel methods using cutting-edge technologies to improve lives with precision diagnostics. She has successfully led development teams through the entire product development life cycle, from feasibility to RUO, CLIA, and IVD grade product launches and post-market support under respective regulatory standards. Prior to Invivoscribe, Dr. Huang worked at Illumina, ACEA Biosciences, Nanogen, and MD Anderson Cancer Center. In those roles, she developed a variety of techniques ranging from isolating CTC using microfluidic devices to detecting biowarfare agents using electronic microarray. Dr. Huang was the PI for research grants from DARPA and NIH. She is the co-author of more than 60 publications and meeting abstracts and is the co-inventor of 9 patents.

Dr. Huang received her Ph.D. in Electrical Engineering from Bangor University, UK, and B.E. in Electronic Engineering from Xidian University, China.